Cargando…
Risk factors, comorbiditiEs and Atherogenic dysLipidaemia in Indian YOUNG patients with dyslipidaemia attending hospital/clinic: REAL YOUNG (dyslipidaemia) study
OBJECTIVE: To evaluate the pattern of dyslipidaemia, risk factors, and comorbidities in young Indian adults with dyslipidaemia. METHODS: A retrospective, multi-centric real-world study included individuals with dyslipidaemia, aged 18 - 45 years, attending to 623 hospitals/clinics across India. Data...
Autores principales: | Iyengar, S. S., Narasingan, S. N., Gandhi, Pramod, Jaipuriar, Navneet, Mahilmaran, Asha, Patil, Sachin, Abhyankar, Mahesh V., Revankar, Santosh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7586548/ https://www.ncbi.nlm.nih.gov/pubmed/33110825 http://dx.doi.org/10.4103/jfmpc.jfmpc_546_20 |
Ejemplares similares
-
Ezetimibe, cardiovascular risk and atherogenic dyslipidaemia
por: Rizzo, Manfredi, et al.
Publicado: (2011) -
Emerging Strategies for the Management of Atherogenic Dyslipidaemia
por: Agarwala, Anandita, et al.
Publicado: (2020) -
New Perspectives on Atherogenic Dyslipidaemia and Cardiovascular Disease
por: Lorenzatti, Alberto J, et al.
Publicado: (2020) -
Diabetic dyslipidaemia
por: C. Thambiah, Subashini, et al.
Publicado: (2021) -
Challenges and practice pattern of dyslipidaemia management in India during COVID-19 pandemic: A cross-sectional survey
por: Abhyankar, Mahesh V., et al.
Publicado: (2020)